MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 160 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $954,920 | +20.0% | 30,219 | -1.8% | 0.00% | – |
| Q2 2023 | $795,761 | +84.8% | 30,760 | +71.6% | 0.00% | – |
| Q1 2023 | $430,559 | +2591.0% | 17,925 | +2332.2% | 0.00% | – |
| Q3 2022 | $16,000 | +77.8% | 737 | +62.7% | 0.00% | – |
| Q2 2022 | $9,000 | – | 453 | +2057.1% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 21 | -93.1% | 0.00% | – |
| Q3 2021 | $6,000 | 0.0% | 303 | -9.3% | 0.00% | – |
| Q2 2021 | $6,000 | -88.0% | 334 | -86.6% | 0.00% | – |
| Q1 2021 | $50,000 | -84.9% | 2,500 | -86.9% | 0.00% | – |
| Q4 2020 | $332,000 | +228.7% | 19,038 | +260.2% | 0.00% | – |
| Q3 2020 | $101,000 | -19.8% | 5,286 | -18.7% | 0.00% | – |
| Q2 2020 | $126,000 | +147.1% | 6,498 | +76.7% | 0.00% | – |
| Q1 2020 | $51,000 | +920.0% | 3,678 | +1465.1% | 0.00% | – |
| Q4 2019 | $5,000 | +150.0% | 235 | +8.3% | 0.00% | – |
| Q3 2019 | $2,000 | – | 217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |